Related Experiment Video
Updated: Jun 2, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
Published on: November 17, 2023
Advantage of biological over physical optimization in prostate cancer?
Thomas Dirscherl1, Judith Alvarez-Moret, Ludwig Bogner
1Department of Radiotherapy, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. thomas.dirscherl@klinik.uni-regensburg.de
Abstract:
The biological effects of an applied dose can be accounted for by using biological objective functions with IMRT. A commonly used concept is the generalized equivalent uniform dose (gEUD), developed by Niemierko. Unlike the equivalent uniform dose (EUD) which is defined for tumor only, the gEUD can be used for both target volume and organs-at-risk (OAR). In this study, the gEUD has been integrated in our in-house inverse treatment planning system DMCO. DMCO is based on an inverse kernel concept and maintains full Monte-Carlo precision. The system applies direct aperture optimization by means of simulated annealing. Thereby DMCO is per se predestined for the optimization of non-quadratic biological objective functions. In this work, the feasibility of gEUD-based optimization with DMCO is investigated and compared to modified physical optimization. A 'pseudo' Pareto study is performed in order to derive the gEUD-parameters 'a' for the volumes-of-interest of a prostate case. The best biological plan is compared to a physically optimized plan, based on dose-volume objectives (DVO). Furthermore, a hybrid objective function (OF) was developed. It consists of both a biological OF for the OARs and a physical OF for the PTV. The plans are compared to another physically optimized plan, which includes additional zero-DVOs in order to further improve OAR-sparing. As a result of the comparisons it turns out, that the biological OF may improve plan quality with regard to the OARs, but at the price of a degradation of the PTV. This disadvantage can be overcome by a hybrid OF, by which the advantages of both biological and physical OF can be combined. With the application of the physical OF with properly set zero-DVOs, a similar or even superior plan quality may be achieved. The physical OFs do not need the time consuming stochastic optimization, which is mandatory in biological optimization and which is included in DMCO. Furthermore, biological evaluation leaves plan quality rather similar compared to physical optimization, but it cares automatically for the target and the OARs.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...